Michel Popielarz

Metabolomics is the most powerful approach to
understand your biological system and solve your problem. However you have to collaborate with the right partner.
Do you consider working with/for Metabolon? Feel free to contact me to discuss how the company is working and avoid any unpleasant surprises...

Responsible for EMEA biopharma market with a focus on western Europe countries.
customers: pharmas, biotechs, CRO, large academic centers

Responsible for the French market (private and public labs) including pre-sales, post-sales and communication marketing.

Responsible for the “Analytical Sciences Products” Division in France.
Lead a team of 10 account managers and agents, 8 application scientists and 1 assistant.
Accountable for Turnover, P&L, local marketing actions, Quality Insurance Sales Process, Revenue recognition and Recruitments. Involved with Service actions, logistic and credit collection

Responsible for the Operetta CLS and Opera Phenix product range in France, Benelux and Turkey.
While I personally manage the entire sales process in France, I must guide the local team in Benelux and Turkey to promote and sell these products.
My responsibilities also include the follow-up of Service and Application's actions as well as financial sales recognition.
Achievements: 225% over 2016Q4 quota, 206% over 2017 quota, 116% over 2018 quota
Customers: major Academic laboratories as well as large and medium Pharma's.

ABL Lyon is a subsidiary of the Mérieux Institute (Lyon, France). We offer services – in the field of Immuno-oncology - that include immuno-assay developments, method validations and Clinical Samples testing. Methods were mainly performed on these platforms Luminex, Meso Scale Discovery, Singulex, Quanterix, ELIspot and BD FACS.

Achievements : Projects with new Sponsors have significantly increased to represent over 70% of the business (was 30% in 2014). The revenues increased in 2015 (+15% vs 2014) and in 2016 (+60% vs 2015).

Customers: Large and medium Pharma's (FR, CH, US) and Biotech's (EU)

FIRALIS is a private company which is active in R&D projects to identify, develop and produce IVD immuno-assays (including antibodies engineering and production) to measure novel biomarkers

I set up a new Services and Sales Department to promote IVD assay kits (ISO13485) and clinical
Sample testing (ISO17025).

Achievements: from 0€ to 800k€ within the first year.

Customers: Large Pharma's (CH,US), Biotech's (EU), Academic (FR)

Meso Scale Discovery (MSD) is a global leader in the development, manufacture, and
Commercialization of innovative multiplex-assays and instruments for the measurement of biomarkers in biological samples. We are offering instruments, consumables and custom immuno-assay development (singleplex and multiplex).
I was responsible for all marketing, sales & after-sales activities in FR, BE, NL, ES, PT, IT).
I built and led a team of 5 persons including Sales Reps, Field Applications Scientists and Service Engineer.

Achievements: Turnoverfrom $0 to $4M within the first 5 years – Exceeded the last 6 years quotas.

Customers: All Biotech's, Pharma's and CRO in western European Countries as well as selected
Academic Lab's.

Distribution channel including European Countries, Eastern European Countries, Scandinavia, Africa and Middle East.
Direct Sales of high value instruments (FLIPR, LJLbioSystem, IonWorks) in FR, IT, ES, BE, NL, LU, PT.

Note: Amersham Biosciences acquired Molecular Dynamics in 1999.

Account Manager, South France

Cellular Biology (JAK/STAT)
Ian Kerr's lab